Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

UBS Maintains Neutral on Stitch Fix, Lowers Price Target to $4.2

UBS analyst Joseph Parkhill maintains Stitch Fix (NASDAQ:SFIX) with a Neutral and lowers the price target from $4.3 to $4.2.
byBenzinga Newsdesk
December 7, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

UBS analyst Joseph Parkhill maintains Stitch Fix (NASDAQ:SFIX) with a Neutral and lowers the price target from $4.3 to $4.2.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

Atara Biotherapeutics To Receive Additional Near-Term Milestone Payment Under Updated Tabelecleucel Commercialization Agreement With Pierre Fabre; Atara To Receive Additional $30M Upon European Commission Approval And Filing Of Tab-Cel

By Benzinga Newsdesk
September 28, 4:03 PM
Atara to Receive Additional USD 30 Million Upon European Commission (EC) Approval and Filing of Tab-cel® Marketing Authorization Transfer to Pierre Fabre Responses Submitted to European Medicines

ATRA